Microplate Dx Limited
Dr Stuart Hannah is the Chief Executive Officer at Microplate Dx Limited. Prior to this role, he was a Knowledge Exchange Fellow and Research Associate at the University of Strathclyde, where he also completed a Doctor of Philosophy degree in Electronic & Electrical Engineering. He has a background in developing flexible/stretchable electronics for biosensing applications, including creating sensors for bladder wall stretch monitoring to aid in the treatment of various conditions. Dr Stuart Hannah also held positions as a Postdoctoral Researcher at École des Mines de Saint-Étienne and as a Royal Society of Edinburgh Enterprise Fellow.
This person is not in any teams
Microplate Dx Limited
Microplate Dx Limited specialises in rapid antibiotic susceptibility testing diagnostics, enabling clinicians, at the point-of-care, to confidently select the best choice of antibiotic to treat a patient’s infection in a matter of minutes, significantly quicker than the current gold standard technology which takes at least 2 days. Our award-wining, platform diagnostic test helps reduce the major global health threat of antimicrobial resistance and ultimately, saves lives.